What You Should Know:
- Override, a new multi-specialty, virtual chronic pain solution founded by former US Secretary of Veterans Affairs, David Shulkin MD, and his daughter, Jennie Shulkin JD emerges from stealth with $3.5M. The seed round was led by 7wireVentures and Martin Ventures, with SignalFire and Confluent Health joining the round.
- In addition, Override has acquired the country’s leading pain management coaching business: Take Courage Coaching.
Virtual Chronic Pain
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Pangea Biomed Adds $5M for its Multi-Cancer Response Predictor
What You Should Know:
- Pangea Biomed, the biotech company behind ENLIGHT, the multi-cancer response predictor improving the effectiveness of precision oncology, announced $5M in additional funding reaching a total seed round of $12M.
- The latest fundraising is led by angel investor Danny Tocatly and existing investor NFX, and will be used to expand US operations, drive commercial partnerships, and scale product offerings.
Expanding US Operations and Fostering Commercial
Read More
BehaVR & Oxford VR Merge, Raises $13M for VR Delivery Platform
What You Should Know:
- Virtual reality mental and behavioral health companies BehaVR and OxfordVR today announced their merger, supported by an initial $13M in Series B funding led by Optum Ventures and Oxford Science Enterprises, with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures and Thornton Capital.
- Uniting under the BehaVR brand, digital therapeutic companies BehaVR and OxfordVR will deliver comprehensive virtual reality-based treatments for mental and
Read More
How My Telehealth Company Used Revenue-Based Financing – not VC – to Get Mental Health Services to Underserved Seniors
Beyond just the impact of COVID-19, the need for tele-mental healthcare and telepsychiatry services continues to expand, especially for rural communities. With the unpredictable venture capital market, startups offering telehealth services increasingly find themselves evaluating alternative financing options.
I’ve noticed a number of alternatives have emerged in the last several years. These can be especially helpful for startups that need quick decisions and have predictable revenue growth
Read More
Serena Williams-Backed Juno Medical Raises $12M to Expand Tech-Enabled Healthcare Clinics
What You Should Know:
- Juno Medical, the modern doctor's office that's designed for the 99% raises $12M in Series A funding co-led by Julian Eison, Managing Partner at NEXT VENTURES, and Serena Williams, Managing Partner at Serena Ventures. Other notable participants include Vast Ventures, which led Juno’s seed round, Empire State Development’s New York Ventures, TXV Partners, Genius Guild, Gaingels, and previous investors Atento Capital and Humbition.
- Juno’s products and services are
Read More
Sonde Health Secures $19.25M for Voice-Based Health Monitoring
What You Should Know:
- Sonde Health, a Boston, MA-based health technology company committed to bringing accessible health monitoring to everyone raises $19.25 million in a Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures.
- The AI vocal biomarker company will use the funding to accelerate its commercial growth, expand its platform into new health
Read More
Japanese Healthcare Startup Ubie Raises $45M for AI Symptom Checker
What You Should Know:
- Ubie, Inc., a Tokyo-based healthcare startup, announced it has closed its Series C round at $45M by raising $19M in an extension round. The new funding will enable Ubie to accelerate its growth and strengthen its presence in the U.S., following strong interest and traction in that market. To date, Ubie has raised $76 million in total.
- With AI as its core technology, Ubie provides AI symptom checker Ubie as the gateway to medical care. It will also focus on
Read More
Vevo Launches with $12M to Scale Vivo Data Generation to Discover Better Drugs
What You Should Know:
- Vevo Therapeutics, an SF-based biotechnology company, launched today with a $12M seed round led by General Catalyst and Wing Venture Capital using its Mosaic in vivo drug discovery platform and next-generation AI models to uncover better drugs for more patients.
- Vevo is the first platform to make in vivo data generation scalable with single-cell precision + will create the world’s largest atlas of how drugs interact with patient cells. In a single in vivo
Read More
CrowdHealth Secures $6M for Community-Powered Alternative to Health Insurance
What You Should Know:
- CrowdHealth recently secured $6 million in Series A funding from Next Coast Ventures and Activate Venture Partners. CrowdHealth plans to reinvest that funding back into the company—growing the CrowdHealth community and providing more tools for members that want to take charge of their healthcare and affordably break free from health insurance.
- Operating under a monthly membership model, CrowdHealth is a healthcare technology company that offers a new way to
Read More
Digital Health VCs Cite ROI & Clinical Validation As Greatest Markers of Company’s Success
What You Should Know:
- Investors in the healthcare technology space believe a measurable return on investment (ROI) and clinical validation of the technology's platform will be the greatest indicators of company success in 2023, according to a new survey of top digital health investors by GSR Ventures.
- ROI was deemed "important" or "very important" to the success of digital health companies by more than 94% of investor respondents, and 79% for clinical evidence and trials.
Top
Read More
